West Pharmaceutical Services Trading Volume Surges 143.61% to $339 Million, Ranks 318th in Daily Market Turnover

On April 30, 2025, West Pharmaceutical Services, Inc. (WST) saw a significant increase in trading volume, with a turnover of $339 million, marking a 143.61% rise from the previous day. This surge placed WST at the 318th position in the daily market rankings. However, the stock price of WST declined by 1.02%, marking the second consecutive day of decline, with a total decrease of 2.23% over the past two days.

West Pharmaceutical Services, Inc. is a company that specializes in the manufacturing and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company recently released its full-year revenue guidance, projecting $2.96 billion at the midpoint, which is 2% above analysts' estimates. Additionally, its non-GAAP profit of $1.45 per share exceeded expectations by 18.1%.

West Pharmaceutical Services is scheduled to report its financial results for the first quarter of 2025 before the market opens on April 24. Analysts anticipate that the company will post revenue of $686.29 million for the quarter, representing a 1.31% year-over-year decrease. The earnings per share (EPS) is estimated to be $1.175, down 24.2% from the same period last year. The company typically hosts a conference call around the date of the financial report publication to discuss its recent financial results and operational performance with investors, analysts, and media.